BLIRT has filed an international patent application for Saltonase!

We are delighted to announce that Blirt has filed for an international patent for Saltonase, which covers this innovative enzyme, its production processes, and a wide range of technological applications.

Saltonase, heat-labile nuclease is intended for use in the purification of gene therapy products; we are looking forward to developing better purification technologies with partners dealing with viral vectors and genetic vaccines.

Let us know if you want to test Saltonase and improve your processes!